Jardiance Met 12.5mg/500mg Tablet
By Jardiance Met
Rx
10 Tablet in a Strip

Composition
Empagliflozin(12.5mg) + Metformin(500mg)

Manufacturer - Boehringer Ingelheim
1102, Hallmark Business Plaza, 11th Floor, Gurunanak Hospital Road, Near Gurunanak Hospital, Bandra (East), Mumbai 400051

Expires on or after
February, 2026

liver
Jardiance Met 12.5mg/500mg Tablet needs to be used carefully in individuals with liver problems. A dosage adjustment may be necessary, so it is important to consult with your doctor before taking this medication if you have any liver disease. Inform your doctor about any history of liver impairment or disorders before using Cospiaq Met 12.5/500 Tablet 10's. Your doctor will assess the situation to ensure that the benefits of the medication outweigh any potential risks.

kidney
Jardiance Met 12.5mg/500mg Tablet may not be safe for patients with kidney disease. Inform your doctor about any kidney history before use. Benefits should outweigh risks for prescription consideration.

alcohol
Caution is advised when drinking alcohol while taking Jardiance Met 12.5mg/500mg Tablet. Alcohol can worsen side effects like lactic acidosis and increase the risk of low blood sugar levels. It is recommended to consult your doctor before consuming alcohol.

driving
Caution Driving may be affected by Jardiance Met 12.5mg/500mg Tablet as it can reduce alertness, cause drowsiness, affect vision, and make you feel dizzy. If you experience these side effects, do not drive to ensure safety. Additionally, extreme blood sugar levels leading to symptoms such as blurred vision, dizziness, or drowsiness can also impair driving ability. It is advisable to refrain from driving or operating machinery in such cases.

pregnancy
Jardiance Met 12.5mg/500mg Tablet may not be safe during pregnancy as animal studies have shown potential harm to the baby. Consult your doctor as they will assess the risks and benefits before prescribing. Opt for alternative medications if pregnant or planning for pregnancy.

breastfeeding
Jardiance Met 12.5mg/500mg Tablet is likely unsafe for breastfeeding mothers. Limited data indicates that the drug can pass into breast milk, potentially harming the baby. It is advisable to consult a healthcare professional for guidance.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹457
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024